US approves fish oil-based drug for cutting heart risks – New Zealand Herald
- US approves fish oil-based drug for cutting heart risks New Zealand Herald
- FDA Approves Amarin’s Vascepa for CV Risk Reduction Medscape
- Amarin eyes blockbuster Vascepa sales as FDA grants heart-helping label expansion FiercePharma
- FDA says Amarin can market fish-oil derived therapy for reducing heart attack risk Reuters
- Amarin’s fish-oil drug approved to prevent heart attacks and strokes STAT
- View full coverage on Google News
Source: Business News Feed